Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-22

Clinical Trial Update: The TANTALUS® II for the Treatment of Type 2 Diabetes [NA]

View source ↗

Summary

Completed clinical trial evaluating TANTALUS II for the treatment of type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TANTALUS II

Snippet

Sponsor: MetaCure (USA), Inc. | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED